17th Oct 2013 09:34
LONDON (Alliance News) - Futura Medical Thursday said it has now received the CE mark it needs to be able to market its new erection-enhancing condom across Europe and other countries that recognise the mark.
The company says the condom, which is lined with a special gel, is clinically proven to produce a firmer erection and increase penile size in healthy men and to give women a longer lasting sexual experience.
It got clearance from Europe regulators for the condom last month, but needed the CE mark to be allowed to market it. CE marking is a declaration by the manufacturer that the product meets all the appropriate provisions of relevant European legislation.
Futura has already licensed distribution rights for the CSD500 condom in North America and key European markets to Church & Dwight, maker of Trojan condoms. It said talks are progressing well with potential licensing partners for other territories within Europe and worldwide, having previously said sales would be launched in three continents in 2014.
"We congratulate Futura on gaining regulatory approval in Europe for CSD500 and we look forward to continuing to work with Futura towards the launch of this extremely novel condom," Church & Dwight's President of International Consumer Products Steven Cugine said in a statement.
Futura Medical shares were up 3.5% ay 67.50 pence Thursday morning.
The company, which specializes in erectile dysfunction, enhanced sexual control and pain relief products, last month said its pretax loss narrowed in the first half of the year as it launched a number of new products in its markets, including two pain relief products.
By Steve McGrath; [email protected]; @stevemcgrath1
Copyright 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
Futura Medical